Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement

P. Woo; N. Wilkinson; A-M. Prieur; T. Southwood; V. Leone; P. Livermore; H. Wythe; D. Thomson; T. Kishimoto

doi:10.1186/ar1826

Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement

P. Woo, N. Wilkinson, A-M. Prieur, T. Southwood, V. Leone, P. Livermore, H. Wythe, D. Thomson, T. Kishimoto

School of Health and Social Work

Research output: Contribution to journal › Article › peer-review

185 Citations (Scopus)

57 Downloads (Pure)

Original language	English
Journal	Arthritis Research and Therapy
Volume	7
Issue number	6
DOIs	https://doi.org/10.1186/ar1826
Publication status	Published - 2005

Access to Document

10.1186/ar1826

901524.pdf

Cite this

Woo, P., Wilkinson, N., Prieur, A.-M., Southwood, T., Leone, V., Livermore, P., Wythe, H., Thomson, D., & Kishimoto, T. (2005). Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Research and Therapy, 7(6). https://doi.org/10.1186/ar1826

Woo, P. ; Wilkinson, N. ; Prieur, A-M. et al. / Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. In: Arthritis Research and Therapy. 2005 ; Vol. 7, No. 6.

@article{6461c5acd252467f9df1cf8d49505a28,

title = "Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement",

author = "P. Woo and N. Wilkinson and A-M. Prieur and T. Southwood and V. Leone and P. Livermore and H. Wythe and D. Thomson and T. Kishimoto",

note = "This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Original article can be found at: http://arthritis-research.com/",

year = "2005",

doi = "10.1186/ar1826",

language = "English",

volume = "7",

journal = "Arthritis Research and Therapy",

issn = "1478-6354",

publisher = "BioMed Central (BMC)",

number = "6",

}

Woo, P, Wilkinson, N, Prieur, A-M, Southwood, T, Leone, V, Livermore, P, Wythe, H, Thomson, D & Kishimoto, T 2005, 'Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement', Arthritis Research and Therapy, vol. 7, no. 6. https://doi.org/10.1186/ar1826

Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. / Woo, P.; Wilkinson, N.; Prieur, A-M. et al.
In: Arthritis Research and Therapy, Vol. 7, No. 6, 2005.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement

AU - Woo, P.

AU - Wilkinson, N.

AU - Prieur, A-M.

AU - Southwood, T.

AU - Leone, V.

AU - Livermore, P.

AU - Wythe, H.

AU - Thomson, D.

AU - Kishimoto, T.

N1 - This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Original article can be found at: http://arthritis-research.com/

PY - 2005

Y1 - 2005

U2 - 10.1186/ar1826

DO - 10.1186/ar1826

M3 - Article

SN - 1478-6354

VL - 7

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

IS - 6

ER -

Woo P, Wilkinson N, Prieur AM, Southwood T, Leone V, Livermore P et al. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Research and Therapy. 2005;7(6). doi: 10.1186/ar1826